Phosphoric chloroquine:2 tablets phosphoric chloroquine BID, complicated with therapy recommended by New Coronavirus Infected Pneumonia Diagnosis and Treatment Scheme (revision of Trial Version 5)
Sponsors
Jingzhou Central Hospital, The Sixth Affiliated Hospital of Guangzhou Medical University (Qingyuan People's Hospital)
Conditions
Novel Coronavirus Pneumonia (COVID-19)
Phase 4
Cancelled by the investigator A randomized, double-blind, parallel, controlled trial for comparison of phosphoric chloroquine combined with standard therapy and standard therapy in mild/common patients with novel coronavirus pneumonia (COVID-19)
Active, not recruitingChiCTR2000029837
Start: 2020-02-17Updated: 2020-03-16
Cancelled by the investigator A randomized, double-blind, parallel, controlled trial for comparison of phosphoric chloroquine combined with standard therapy and standard therapy in mild/common patients with novel coronavirus pneumonia (COV
ChiCTR2000030031
Start: 2020-02-20Updated: 2020-03-16